Stockhub

Evgen Pharma plc: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

3 September 2022

  • curprev 07:5407:54, 3 September 2022 95.149.241.133 talk 815 bytes +815 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company's lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the tre..."
Retrieved from "https://stockhub.co/research/Evgen_Pharma_plc"